Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
This bulletin is based on the equivalent bulletin produced by Bodleian Health Care Libraries:
COVID-19 infection and vaccination during first trimester and risk of congenital anomalies 10.1136/bmj-2024-079364
Inguinal and femoral hernias 10.1136/bmj-2024-079531
Insulin for people with type 2 diabetes mellitus 10.1136/bmj-2023-078015
Trends in long term vaping among adults in England, 2013-23 10.1136/bmj-2023-079016
A clinical diagnostic test for calcium release deficiency syndrome 10.1001/jama.2024.8599
Interventions for weight management in children and adolescents: updated evidence report and systematic review for the US Preventive Services Task Force 10.1001/jama.2024.6739
Kidney transplant outcomes from deceased donors who received dialysis 10.1001/jama.2024.8469
Clinical effectiveness and safety of time-lapse imaging systems for embryo incubation and selection in in-vitro fertilisation treatment (TILT) 10.1016/S0140-6736(24)00816-X
Colorectal cancer (review) 10.1016/S0140-6736(24)00360-X
Counting the dead in Gaza: difficult but essential 10.1016/S0140-6736(24)01169-3
Livebirth rate after one frozen embryo transfer in ovulatory women starting with natural, modified natural, or artificial endometrial preparation in Viet Nam 10.1016/S0140-6736(24)00756-6
Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke 10.1016/S0140-6736(24)01028-6
Neonatal bacterial sepsis (review) 10.1016/S0140-6736(24)00495-1
Efanesoctocog alfa prophylaxis for children with severe hemophilia A 10.1056/NEJMoa2312611
Management of insomnia (clinical practice review) 10.1056/NEJMcp2305655
Oral nirmatrelvir–ritonavir as postexposure prophylaxis for COVID-19 10.1056/NEJMoa2309002
Risankizumab versus ustekinumab for moderate-to-severe crohn’s disease 10.1056/NEJMoa2314585
Tenecteplase for ischemic stroke at 4.5 to 24 hours without thrombectomy 10.1056/NEJMoa2402980
Does frailty need a new name? 10.1136/bmj-2023-076862
Effectiveness of behavioural interventions with motivational interviewing on physical activity outcomes in adults 10.1136/bmj-2023-078713
Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson’s disease (PD COMM) 10.1136/bmj-2023-078341
New and emerging treatments for major depressive disorder 10.1136/bmj-2022-073823
Association between cost sharing and naloxone prescription dispensing 10.1001/jama.2024.8378
Electroencephalography-guided anesthesia and delirium in older adults after cardiac surgery (ENGAGES-Canada) 10.1001/jama.2024.8144
The integration of clinical trials with the practice of medicine: repairing a house divided 10.1001/jama.2024.4088
Management of depression in adults: a review 10.1001/jama.2024.5756
Mortality and morbidity in adults with rheumatic heart disease 10.1001/jama.2024.8258
Call to action for a life course approach 10.1016/S0140-6736(24)00826-2
Epidemiology and management of gestational diabetes 10.1016/S0140-6736(24)00825-0
Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack) 10.1016/S0140-6736(24)00755-4
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE) 10.1016/S0140-6736(24)00968-1
Pathophysiology from preconception, during pregnancy and beyond 10.1016/S0140-6736(24)00827-4
Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91) 10.1016/S0140-6736(24)00537-3
Bulevirtide combined with pegylated interferon for chronic hepatitis D 10.1056/NEJMoa2314134
Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes 10.1056/NEJMoa2403347
Nirsevimab and hospitalization for RSV bronchiolitis 10.1056/NEJMoa2314885
Nutrition in medicine: malnutrition in adults 10.1056/NEJMra2212159
A randomized phase 2 trial of felzartamab in antibody-mediated rejection 10.1056/NEJMoa2400763
Acute painful crisis in adults with sickle cell disease 10.1136/bmj-2023-075099
Analgesia for non-specific low back pain 10.1136/bmj-2024-080064
Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3) 10.1136/bmj-2023-079061
Peer support in chronic health conditions 10.1136/bmj-2022-070443
Reducing unnecessary investigations in paediatric seizures in the emergency department 10.1136/bmj-2023-076814
SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice 10.1136/bmj-2023-078483
Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years 10.1136/bmj-2023-078523
An adaptive behavioral intervention for weight loss management 10.1001/jama.2024.0821
Chronic pruritus: a review 10.1001/jama.2024.4899
Home blood pressure telemonitoring and nurse case management in black and Hispanic patients with stroke 10.1001/jama.2024.6609
Long-term outcomes in patients using protocol-directed active surveillance for prostate cancer 10.1001/jama.2024.6695
Revisiting race and the benefit of RAS blockade in heart failure: a meta-analysis of randomized clinical trials 10.1001/jama.2024.6774
Survival benefit associated with participation in clinical trials of anticancer drugs: a systematic review and meta-analysis 10.1001/jama.2024.6281
Text messages with financial incentives for men with obesity 10.1001/jama.2024.7064
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2) 10.1016/S0140-6736(24)00701-3
Burr-hole drainage with or without irrigation for chronic subdural haematoma (FINISH) 10.1016/S0140-6736(24)00686-X
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT) 10.1016/S0140-6736(24)00745-1
Early versus delayed weight-bearing following operatively treated ankle fracture (WAX) 10.1016/S0140-6736(24)00710-4
Effectiveness of ferritin-guided donation intervals in whole-blood donors in the Netherlands (FIND'EM) 10.1016/S0140-6736(24)01085-7
Germany's role in global health at a critical juncture 10.1016/S0140-6736(24)00936-X
Peptic ulcer disease (review) 10.1016/S0140-6736(24)00155-7
Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR) 10.1016/S0140-6736(24)00687-1
Stroke (review) 10.1016/S0140-6736(24)00642-1
Acute abdomen in the modern era 10.1056/NEJMra2304821
Brigatinib in NF2-related schwannomatosis with progressive tumors 10.1056/NEJMoa2400985
Dupilumab for COPD with blood eosinophil evidence of type 2 inflammation 10.1056/NEJMoa2401304
Dupilumab for eosinophilic esophagitis in patients 1 to 11 years of age 10.1056/NEJMoa2312282
Efficacy and safety of donidalorsen for hereditary angioedema 10.1056/NEJMoa2402478
Eosinophil depletion with benralizumab for eosinophilic esophagitis 10.1056/NEJMoa2313318
Normalization of C1 inhibitor in a patient with hereditary angioedema 10.1056/NEJMoa2400403
Oral sebetralstat for on-demand treatment of hereditary angioedema attacks 10.1056/NEJMoa2314192
Reteplase versus alteplase for acute ischemic stroke 10.1056/NEJMoa2400314
Stress ulcer prophylaxis during invasive mechanical ventilation 10.1056/NEJMoa2404245
Systemic light chain amyloidosis (review) 10.1056/NEJMra2304088
Tisotumab vedotin as second- or third-line therapy for recurrent cervical cancer 10.1056/NEJMoa2313811